94 related articles for article (PubMed ID: 29389085)
1. Too much of a good thing! additional studies in this issue.
Preffer F
Cytometry B Clin Cytom; 2018 Jan; 94(1):14-15. PubMed ID: 29389085
[No Abstract] [Full Text] [Related]
2. Flow cytometric immunophenotyping of cerebrospinal fluid specimens.
Craig FE; Ohori NP; Gorrill TS; Swerdlow SH
Am J Clin Pathol; 2011 Jan; 135(1):22-34. PubMed ID: 21173121
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic stability of CD200 expression in plasma cell myeloma.
Olteanu H; Harrington AM; Kroft SH
Am J Clin Pathol; 2012 Jun; 137(6):1013-4. PubMed ID: 22586062
[No Abstract] [Full Text] [Related]
4. Hematologic Malignancies Discovered on Investigation of Breast Abnormalities.
Alsadi A; Lin D; Alnajar H; Brickman A; Martyn C; Gattuso P
South Med J; 2017 Oct; 110(10):614-620. PubMed ID: 28973700
[TBL] [Abstract][Full Text] [Related]
5. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
Xerri L; Chetaille B; Serriari N; Attias C; Guillaume Y; Arnoulet C; Olive D
Hum Pathol; 2008 Jul; 39(7):1050-8. PubMed ID: 18479731
[TBL] [Abstract][Full Text] [Related]
6. Small cell pleomorphic T-cell lymphoma presenting with cutaneous vasculitis.
Gran JT; Sund S; Langholm R
Clin Rheumatol; 1994 Dec; 13(4):628-30. PubMed ID: 7697968
[TBL] [Abstract][Full Text] [Related]
7. Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
Karawajew L; Dworzak M; Ratei R; Rhein P; Gaipa G; Buldini B; Basso G; Hrusak O; Ludwig WD; Henze G; Seeger K; von Stackelberg A; Mejstrikova E; Eckert C
Haematologica; 2015 Jul; 100(7):935-44. PubMed ID: 26001791
[TBL] [Abstract][Full Text] [Related]
8. Transformation of chronic lymphocytic leukemia into B-cell acute lymphoblastic leukemia.
Yun S; Zhang L; Patel MR; Knepper TC; Chavez JC; Pinilla-Ibarz J
Blood; 2018 Mar; 131(11):1258-1261. PubMed ID: 29437555
[No Abstract] [Full Text] [Related]
9. Prostaglandin E2 induces growth inhibition, apoptosis and differentiation in T and B cell-derived acute lymphoblastic leukemia cell lines (CCRF-CEM and Nalm-6).
Soleymani Fard S; Jeddi Tehrani M; Ardekani AM
Prostaglandins Leukot Essent Fatty Acids; 2012 Jul; 87(1):17-24. PubMed ID: 22749740
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process.
Letestu R; Rawstron A; Ghia P; Villamor N; Boeckx N; Boettcher S; Buhl AM; Duerig J; Ibbotson R; Kroeber A; Langerak A; Le Garff-Tavernier M; Mockridge I; Morilla A; Padmore R; Rassenti L; Ritgen M; Shehata M; Smolewski P; Staib P; Ticchioni M; Walker C; Ajchenbaum-Cymbalista F
Cytometry B Clin Cytom; 2006 Jul; 70(4):309-14. PubMed ID: 16906588
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood manifestations of lymphoma and solid tumors.
Hernandez AM
Clin Lab Med; 2002 Mar; 22(1):215-52. PubMed ID: 11933576
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases.
Karube K; Aoki R; Nomura Y; Yamamoto K; Shimizu K; Yoshida S; Komatani H; Sugita Y; Ohshima K
Pathol Int; 2008 Feb; 58(2):89-97. PubMed ID: 18199158
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of lymphoid enhancer-binding factor 1 in diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma.
Amador-Ortiz C; Goolsby CL; Peterson LC; Wolniak KL; McLaughlin JL; Gao J; Chen YH
Am J Clin Pathol; 2015 Feb; 143(2):214-22. PubMed ID: 25596247
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic significance of clinical factors and histological data in gastric lymphomas].
Carli A; Ruggieri G; Savelli V; Grimaldi L; Brocchi L; Addobbati A; Brandi C
Minerva Chir; 1992 Mar; 47(5):285-8. PubMed ID: 1594128
[No Abstract] [Full Text] [Related]
15. [Chronic lymphocytic leukemia concurrent with myeloid/natural killer cell precursor acute leukemia diagnosis].
Morabito L; Raya Sánchez JM; Hernández García MT; Hernández Nieto L
Med Clin (Barc); 2008 Sep; 131(9):356. PubMed ID: 18817657
[No Abstract] [Full Text] [Related]
16. Precursor B-cell lymphoblastic lymphoma presenting as solitary infiltrative plaque in a child.
Choi JE; Ahn HH; Kye YC; Kim SN
Acta Derm Venereol; 2008; 88(3):282-4. PubMed ID: 18480935
[No Abstract] [Full Text] [Related]
17. Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: method and significance.
Dworzak MN; Fritsch G; Panzer-Grümayer ER; Mann G; Gadner H
Leuk Lymphoma; 2000 Jul; 38(3-4):295-308. PubMed ID: 10830736
[TBL] [Abstract][Full Text] [Related]
18. Case study interpretation-New Orleans: case 4. Richter syndrome characterized by diffuse large B cell lymphoma in the context of prior chronic lymphocytic leukemia/small lymphocytic lymphoma.
Linden MA
Cytometry B Clin Cytom; 2013; 84(5):350-3. PubMed ID: 23283841
[No Abstract] [Full Text] [Related]
19. Marked Variability in Reported Minimal Residual Disease Lower Level of Detection of 4 Hematolymphoid Neoplasms: A Survey of Participants in the College of American Pathologists Flow Cytometry Proficiency Testing Program.
Keeney M; Halley JG; Rhoads DD; Ansari MQ; Kussick SJ; Karlon WJ; Mehta KU; Dorfman DM; Linden MA
Arch Pathol Lab Med; 2015 Oct; 139(10):1276-80. PubMed ID: 25695342
[TBL] [Abstract][Full Text] [Related]
20. Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20(+) rituximab-sensitive/-resistant Burkitt lymphoma (BL) and precursor B-acute lymphoblastic leukaemia (pre-B-ALL): potential targeted therapy in patients with poor risk CD20(+) BL and pre-B-ALL.
Awasthi A; Ayello J; Van de Ven C; Elmacken M; Sabulski A; Barth MJ; Czuczman MS; Islam H; Klein C; Cairo MS
Br J Haematol; 2015 Dec; 171(5):763-75. PubMed ID: 26471982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
